Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;111(7):742-749.
doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.

Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany

Affiliations

Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany

Peter Stachon et al. Clin Res Cardiol. 2022 Jul.

Abstract

Background: Recent randomized controlled trials have sparked debate about the optimal treatment of patients suffering from left main coronary artery disease. The present study analyzes outcomes of left main stenting versus coronary bypass grafting (CABG) in a nationwide registry in patients with chronic coronary syndrome (CCS).

Methods: All cases suffering from CCS and left main coronary artery disease treated either with CABG or stent, were identified within the database of the German bureau of statistics. Logistic or linear regression models were used with 20 baseline patient characteristics as potential confounders to compare both regimens.

Results: In 2018, 1318 cases with left main stenosis were treated with CABG and 8,920 with stent. Patients assigned for stenting were older (72.58 ± 9.87 vs. 68.63 ± 9.40, p < 0.001) and at higher operative risk, as assessed by logistic EuroSCORE (8.77 ± 8.45 vs. 4.85 ± 4.65, p < 0.001). After risk adjustment, no marked differences in outcomes were found for in-hospital mortality and stroke (risk adjusted odds ratio (aOR) for stent instead of CABG: aOR mortality: 1.08 [95% CI 0.66; 1.78], p = 0.748; aOR stroke: 0.59 [0.27; 1.32], p = 0.199). Stent implantation was associated with a reduced risk of relevant bleeding (aOR 0.38 [0.24; 0.61], p < 0.001), reduced prolonged ventilation time (aOR 0.54 [0.37 0.79], p = 0.002), and postoperative delirium (aOR 0.16 [0.11; 0.22], p < 0.001). Furthermore, stent implantation was associated with shorter hospital stay (- 6.78 days [- 5.86; - 7.71], p < 0.001) and lower costs (- €10,035 [- €11,500; - €8570], p < 0.001).

Conclusion: Left main stenting is a safe and effective treatment option for CCS-patients suffering from left main coronary artery disease at reasonable economic cost. Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. All cases with chronic coronary syndrome and left main stenosis treated in 2018 in Germany either with left main stenting or coronary bypass grafting were extracted from a nation-wide database. In-hospital outcomes were compared after logistic regression analysis.

Keywords: Coronary artery bypass grafting; Left main coronary artery disease; Stent; mortality.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest.

Figures

None
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. All cases with chronic coronary syndrome and left main stenosis treated in 2018 in Germany either with left main stenting or coronary bypass grafting were extracted from a nation-wide database. In-hospital outcomes were compared after logistic regression analysis.
Fig. 1
Fig. 1
CABG vs. stent distribution in clinical practice in 2018. All cases with diagnosis of left main stenosis without STEMI, NSTEMI, unstable angina, in-stent stenosis, and without any other concomitant heart valve surgery were identified
Fig. 2
Fig. 2
Risk-adjusted in-hospital outcomes. Results of multivariable logistic regression analyses with predefined baseline patient characteristics included as potential confounders (all covariates listed in Table 1)

References

    1. European Coronary Surgery Study Group Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet. 1982;2:1173–1180. - PubMed
    1. Ahmad Y, Howard JP, Arnold AD, Cook CM, Prasad M, Ali ZA, Parikh MA, Kosmidou I, Francis DP, Moses JW, Leon MB, Kirtane AJ, Stone GW, Karmpaliotis D. Mortality after drug-eluting stents vs coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials. Eur Heart J. 2020 doi: 10.1093/eurheartj/ehaa135. - DOI - PMC - PubMed
    1. Awad WI, Idhrees M, Kennon S, Bashir M. Coronary artery bypass grafting surgery versus percutaneous coronary intervention: what is the clinical decision framework amid COVID-19 era? J Card Surg. 2020;35:2464–2466. doi: 10.1111/jocs.14833. - DOI - PMC - PubMed
    1. Benetti FJ, Awad WI, Idhrees M, Kennon S, Bashir M. Coronary artery bypass grafting surgery versus percutaneous coronary intervention: what is the clinical decision framework amid COVID-19 era. J Card Surg. 2020;35:2467–2468. doi: 10.1111/jocs.14832. - DOI - PMC - PubMed
    1. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011;57:538–545. doi: 10.1016/j.jacc.2010.09.038. - DOI - PubMed

MeSH terms